Among those with non-insulin-dependent diabetes mellitus within the ID cohort, people in special housing were more likely to be prescribed intermediate-acting insulins and analogues for injection (RR 1.21 [0.81–1.82]) and sulfonylureas (1.11 [0.83–1.49]). This evidence concerns the gene INS and type 1 diabetes mellitus.